Median (min -max) | Silver- coated group (SCG) | non silver-coated Group (NSCG) | Statistical significance (α = 0.05) |
---|---|---|---|
Multiple-stage prosthesis replacement (bone cement spacer) | 16/20 (80%) | 10/14 (71%) | 0.81 |
Multiple-stage prosthesis replacement (temporary girdlestone) | 2/20 (10%)a | 1/14 (7%) | 0.71 |
One-stage prosthesis replacement | 4/20 (20%) | 3/14 (21%) | 0.61 |
Number of revisions up to reimplantation (median; min -max) | 4 (0–10) | 4 (0–7) | 0.19 |
Time to reimplantation after initiation of infection therapy in months | 3 (0–10) | 4 (0–24) | 0.28 |
Reimplantation time in minutes | 188 (128–236) | 193 (122–277) | 0.51 |
Time spent in the hospital for infectious treatment | 22 (10–139) | 32 (14–158) | 0.74 |
C- reaktive proteine (CRP) at discharge (mg/dl) | 17.5 (4.3–89) | 18.2 (1.5–89) | 0.39 |
Leukocytes at discharge (10exp9) | 7 (5–10.5) | 6,6 (4.7–10) | 0.92 |